Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cytomegalovirus colitis following azacitidine therapy.

Literature DB >> 22942891

Cytomegalovirus colitis following azacitidine therapy.

Rajal Khan¹, Pam Rudkin, Kuljit Grewal, Jennifer Leonard, Mowafak Hamodat, Jim Hutchinson, Peter Daley.

Abstract

The present report describes the first recognized case of cytomegalovirus (CMV) colitis following azacitidine therapy. A 66-year-old woman with myelodysplastic syndrome developed CMV colitis, which responded to treatment with ganciclovir. Currently, patients receiving azacitidine do not undergo CMV testing, or receive prophylaxis or CMV-free blood products; however, this policy needs to be revised.

Entities: Chemical Disease Species

Keywords: Azacitidine; CMV; Colitis

Year: 2011 PMID： 22942891 PMCID： PMC3200377 DOI： 10.1155/2011/616725

Source DB: PubMed Journal: Can J Infect Dis Med Microbiol ISSN： 1712-9532 Impact factor: 2.471

22 in total

1. Gene transfer to hepatocellular carcinoma: transduction efficacy and transgene expression kinetics by using retroviral and lentiviral vectors.

Authors: R Gerolami; R Uch; F Jordier; S Chapel; C Bagnis; C Bréchot; P Mannoni
Journal: Cancer Gene Ther Date: 2000-09 Impact factor: 5.987

2. Effects of epigenetic modulation on reporter gene expression: implications for stem cell imaging.

Authors: Manickam Krishnan; Jinha M Park; Feng Cao; Dongxu Wang; Ramasay Paulmurugan; Jeffrey R Tseng; Mark L Gonzalgo; Sanjiv S Gambhir; Joseph C Wu
Journal: FASEB J Date: 2005-10-24 Impact factor: 5.191

3. Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B.

Authors: Lewis R Silverman; Erin P Demakos; Bercedis L Peterson; Alice B Kornblith; Jimmie C Holland; Rosalie Odchimar-Reissig; Richard M Stone; Douglas Nelson; Bayard L Powell; Carlos M DeCastro; John Ellerton; Richard A Larson; Charles A Schiffer; James F Holland
Journal: J Clin Oncol Date: 2002-05-15 Impact factor: 44.544

Review 4. Cytomegalovirus disease in the era of highly active antiretroviral therapy (HAART).

Authors: Christoph Steininger; Elisabeth Puchhammer-Stöckl; Theresia Popow-Kraupp
Journal: J Clin Virol Date: 2006-05-03 Impact factor: 3.168

5. Approval summary: azacitidine for treatment of myelodysplastic syndrome subtypes.

Authors: Edvardas Kaminskas; Ann Farrell; Sophia Abraham; Amy Baird; Li-Shan Hsieh; Shwu-Luan Lee; John K Leighton; Hasmukh Patel; Atiqur Rahman; Rajeshwara Sridhara; Yong-Cheng Wang; Richard Pazdur
Journal: Clin Cancer Res Date: 2005-05-15 Impact factor: 12.531

2. Cytomegalovirus Colitis Masquerading as Apple-Core Lesion after Systemic Chemotherapy in a Patient with Relapsed Acute Myeloid Leukemia.

Authors: Jong An; Jason Brownell; Darrell Barker; Theresa Stockinger; Robert Brady; Katherine Cebe; Russell Baur
Journal: Case Rep Oncol Med Date: 2018-03-20

2 in total

Cytomegalovirus colitis following azacitidine therapy.

1. Gene transfer to hepatocellular carcinoma: transduction efficacy and transgene expression kinetics by using retroviral and lentiviral vectors.

2. Effects of epigenetic modulation on reporter gene expression: implications for stem cell imaging.

3. Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B.

Review 4. Cytomegalovirus disease in the era of highly active antiretroviral therapy (HAART).

5. Approval summary: azacitidine for treatment of myelodysplastic syndrome subtypes.

6. Severe cytomegalovirus enterocolitis after standard chemotherapy for non-Hodgkin's lymphoma.

7. Cytomegalovirus pneumonia in patients with lymphoma.

8. Cytomegalovirus colitis after 5-fluorouracil and interferon-alpha therapy.

9. Detection of cytomegalovirus reactivation in cancer patients receiving chemotherapy.

10. Cell type-specific activation of the cytomegalovirus promoter by dimethylsulfoxide and 5-aza-2'-deoxycytidine.

1. CMV Colitis: A Rare Complication of Azacitidine and Venetoclax Chemotherapy.

2. Cytomegalovirus Colitis Masquerading as Apple-Core Lesion after Systemic Chemotherapy in a Patient with Relapsed Acute Myeloid Leukemia.